News

Hylomorph secures CHF 5.2 million series-B round

The clinical-stage startup aims to minimise post-surgical complications in medical implants. Proceeds from its CHF 5.2 series B investment CHF 0.9 Million non-dilutive funding will support the company in obtaining the FDA and CE mark approval for its product portfolio, beginning with the Hylomate.

weiterlesen

CareerFairy secures CHF 1.7 million seed capital

ETH spinoff CareerFairy AG has completed its seed investment round led by the venture arm of Swiss Post together with Zurich-based VC BackBone Ventures and other prominent business angels. The funds will help accelerate the digitalisation of corporate events at universities and open up even more markets internationally.

weiterlesen

Vifor Pharma to acquire Inositec

Vifor Pharma has announced the acquisition of Inositec AG, a Swiss start-up, developing first-in-class non-dialysis treatments for soft tissue and vascular calcification disorders. Inositec purchase price includes an upfront payment of CHF 20 million and success based clinical earn-out payments.

weiterlesen

Travel Expenses Startup worth $100 million in Fund Raiser

Yokoy Group AG has raised about $26 million in a funding round led by Left Lane Capital, with participation from Balderton Capital, the Zurich-based firm said in an emailed statement.
The funds will be used to expand in Europe and the U.S., Chief Executive Officer Philippe Sahli said.

weiterlesen